Fidelity Investments’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Fidelity Investments's PACB Position: Q3 2026 in Review
Fidelity Investments increased its Pacific Biosciences (PACB) stake by 1.9% in Q3 2026, buying an estimated $668 and bringing the position to 25,815 shares worth $61.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4255.
Fidelity Investments first reported a position in PACB in Q4 2014 and has held it in 26 quarters since. The position peaked at $99.1M in Q1 2021. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Fidelity Investments held 25,815 shares of Pacific Biosciences worth $61.2K as of Q3 2026.
- Fidelity Investments bought 473 Pacific Biosciences shares in Q3 2026, an estimated $668.
- Pacific Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4255 holding.
- Fidelity Investments first reported a position in Pacific Biosciences in Q4 2014 and has held it in 26 quarters since.
- Fidelity Investments's Pacific Biosciences position peaked at $99.1M in Q1 2021.
- 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.